Fig. 14 | Scientific Reports

Fig. 14

From: Synergistic anticancer activity of frankincense aqueous extract with sorafenib in HepG2 cells and its UHPLC–QTOF–MS/MS-based metabolomic profiling

Fig. 14The alt text for this image may have been generated using AI.

(a) Evaluation of the anti-migratory activity of frankincense aqueous extract (FrAE, 25 µg/ml), sorafenib (SOR, 2 µM), and their combination (9 μg/ml FrAE + 0.9 µm SOR), corresponding to a 10:1 combination ratio treatment on HepG2 cell migration using the scratch assay. Widths were assessed at 24, 48, 72, and 96 h post-treatment. (b) Data were plotted as wound closure percentage at each time point and represented as mean ± SD; n = 3. *Statistically significant from control, #significantly different from the sorafenib group at p < 0.0001.

Back to article page